Skandinaviska Enskilda Banken AB »

Recro Pharma shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $775k 717k 1.08

More positions owned by Skandinaviska Enskilda Banken AB

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Merck & Co (MRK)
Advanced Micro Devices (AMD)
Mastercard Incorporated Cl A (MA)
Abbvie (ABBV)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
UnitedHealth (UNH)

View all positions for Skandinaviska Enskilda Banken AB

Top funds holding Recro Pharma

First Light Asset Management
Beryl Capital Management
AWM Investment Company
Vanguard Group
OV Management
Geode Capital Management
Trium Capital
Vazirani Asset Management
Skandinaviska Enskilda Banken AB
Crystalline Management
BlackRock
Clear Harbor Asset Management
FNY Investment Advisers
Samjo Management
Bridgeway Capital Management

View all funds holding Recro Pharma